AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
-3.8%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.7B
AUM Growth
-$280M
Cap. Flow
-$30.2M
Cap. Flow %
-0.82%
Top 10 Hldgs %
93.38%
Holding
91
New
11
Increased
19
Reduced
11
Closed
15

Top Buys

1
ALXN
Alexion Pharmaceuticals Inc
ALXN
$24.5M
2
ATH
Athene Holding Ltd. Class A Common Shares
ATH
$19.2M
3
AGIO icon
Agios Pharmaceuticals
AGIO
$14.6M
4
ZTO icon
ZTO Express
ZTO
$12.1M
5
CELG
Celgene Corp
CELG
$11.6M

Top Sells

1
GS icon
Goldman Sachs
GS
$32.3M
2
ARRY
Array Biopharma Inc
ARRY
$19.8M
3
BAC icon
Bank of America
BAC
$15.7M
4
MS icon
Morgan Stanley
MS
$11.2M
5
APTV icon
Aptiv
APTV
$10.7M

Sector Composition

1 Consumer Staples 56.99%
2 Healthcare 31.66%
3 Consumer Discretionary 9.71%
4 Financials 0.52%
5 Industrials 0.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NBIX icon
26
Neurocrine Biosciences
NBIX
$13.5B
$5.81M 0.13%
150,000
+50,000
+50% +$1.94M
SRPT icon
27
Sarepta Therapeutics
SRPT
$1.98B
$5.49M 0.12%
200,000
– –
LCTX icon
28
Lineage Cell Therapeutics
LCTX
$281M
$4.63M 0.1%
1,465,383
– –
RXDX
29
DELISTED
Ignyta, Inc.
RXDX
$4.51M 0.1%
850,000
– –
ELF icon
30
e.l.f. Beauty
ELF
$7.38B
$4.34M 0.1%
150,000
– –
MGNX icon
31
MacroGenics
MGNX
$121M
$4.09M 0.09%
200,000
+50,000
+33% +$1.02M
CCXI
32
DELISTED
ChemoCentryx, Inc.
CCXI
$4.04M 0.09%
546,278
-653,722
-54% -$4.84M
XLRN
33
DELISTED
Acceleron Pharma Inc.
XLRN
$3.83M 0.09%
150,000
-25,000
-14% -$638K
RDUS
34
DELISTED
Radius Health, Inc.
RDUS
$3.8M 0.08%
100,000
+50,000
+100% +$1.9M
JUNO
35
DELISTED
Juno Therapeutics, Inc.
JUNO
$3.77M 0.08%
200,000
– –
SIOX
36
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$3.73M 0.08%
37,500
+6,250
+20% +$621K
GBT
37
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.56M 0.08%
246,054
+146,054
+146% +$2.11M
RARE icon
38
Ultragenyx Pharmaceutical
RARE
$3.04B
$3.52M 0.08%
50,000
– –
NTLA icon
39
Intellia Therapeutics
NTLA
$1.26B
$3.28M 0.07%
250,000
+45,000
+22% +$590K
ACIU icon
40
AC Immune
ACIU
$227M
$3.25M 0.07%
250,000
+100,000
+67% +$1.3M
LOXO
41
DELISTED
Loxo Oncology, Inc
LOXO
$3.21M 0.07%
100,000
+25,000
+33% +$803K
RGNX icon
42
Regenxbio
RGNX
$498M
$2.97M 0.07%
160,000
-140,000
-47% -$2.6M
NERV icon
43
Minerva Neurosciences
NERV
$16.8M
$2.95M 0.07%
31,413
+6,413
+26% +$603K
CLLS
44
Cellectis
CLLS
$260M
$2.54M 0.06%
150,000
– –
ONCE
45
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.5M 0.06%
50,000
– –
CLDX icon
46
Celldex Therapeutics
CLDX
$1.57B
$2.39M 0.05%
45,000
– –
CMRX
47
DELISTED
Chimerix, Inc.
CMRX
$2.3M 0.05%
500,000
– –
CLVS
48
DELISTED
Clovis Oncology, Inc.
CLVS
$2.22M 0.05%
+50,000
New +$2.22M
NVLN
49
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$2.16M 0.05%
+256,400
New +$2.16M
MDCO
50
DELISTED
Medicines Co
MDCO
$1.7M 0.04%
+50,000
New +$1.7M
1
2
3 4